The Emerging Molecular Landscape of Urothelial Carcinoma

James P. Solomon, Donna E. Hansel

Research output: Contribution to journalReview articlepeer-review

20 Scopus citations

Abstract

Although there have been many recent discoveries in the molecular alterations associated with urothelial carcinoma, current understanding of this disease lags behind many other malignancies. Historically, a two-pathway model had been applied to distinguish low- and high-grade urothelial carcinoma, although significant overlap and increasing complexity of molecular alterations has been recently described. In many cases, mutations in HRAS and FGFR3 that affect the MAPK and PI3K pathways seem to be associated with noninvasive low-grade papillary tumors, whereas mutations in TP53 and RB that affect the G1-S transition of the cell cycle are associated with high-grade in situ and invasive carcinoma. However, recent large-scale analyses have identified overlap in these pathways relative to morphology, and in addition, many other variants in a wide variety of oncogenes and tumor-suppressor genes have been identified. New technologies including next-generation sequencing have enabled more detailed analysis of urothelial carcinoma, and several groups have proposed molecular classification systems based on these data, although consensus is elusive. This article reviews the current understanding of alterations affecting oncogenes and tumor-suppressor genes associated with urothelial carcinoma, and their application in the context of morphology and classification schema.

Original languageEnglish (US)
Pages (from-to)391-404
Number of pages14
JournalSurgical Pathology Clinics
Volume9
Issue number3
DOIs
StatePublished - Sep 1 2016
Externally publishedYes

Keywords

  • Ancillary testing
  • Bladder cancer
  • Immunotherapy
  • Molecular pathology
  • Subclassification
  • Targeted therapy
  • Urothelial carcinoma

ASJC Scopus subject areas

  • Surgery
  • Pathology and Forensic Medicine

Fingerprint

Dive into the research topics of 'The Emerging Molecular Landscape of Urothelial Carcinoma'. Together they form a unique fingerprint.

Cite this